Showing 1 - 20 results of 45 for search 'Repapi, E', 查詢時間: 0.03s
Refine Results
-
1
-
2
CTAS - A CT score to quantify disease activity in pulmonary sarcoidosis 由 Ho, L, Benamore, R, Kendrick, Y, Repapi, E, Helm, E, Cole, S, Taylor, S
出版 2016Journal article -
3
CTAS – a ct score to quantify disease activity in pulmonary sarcoidosis 由 Kendrick, Y, Repapi, E, Helm, E, Cole, S, Hoyles, R, Benamore, R, Ho, L
出版 2016Journal article -
4
-
5
No evidence for age-related differences in mtRNA quality in the female germline 由 Hartley, FM, Alageel, A, Appeltant, R, Gray, N, Repapi, E, Wells, D, Williams, SA, Poulton, J
出版 2022Journal article -
6
-
7
-
8
-
9
MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation. 由 Godfrey, L, Kerry, J, Thorne, R, Repapi, E, Davies, J, Tapia, M, Ballabio, E, Hughes, J, Geng, H, Konopleva, M, Milne, T
出版 2016Journal article -
10
Single cell spatial analysis of lungs from patients with fatal COVID-19 reveals a cellular network marked by inflammatory foci of immature neutrophil and CD8 T cells localised to a... 由 Weeratunga, P, Denney, L, Bull, J, Repapi, E, Sergeant, M, Vuppusetty, C, C Cosmic Consortium, Byrne, H, Taylor, S, Ho, L-P
出版 2023Conference item -
11
-
12
CD1a presentation of endogenous antigens by group 2 innate lymphoid cells 由 Hardman, C, Chen, Y, Salimi, M, Jarrett, R, Johnson, D, Jarvinen, V, Owens, R, Repapi, E, Cousins, D, Barlow, J, McKenzie, A, Ogg, G
出版 2017Journal article -
13
-
14
The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin 由 Truch, J, Downes, DJ, Scott, C, Gür, ER, Telenius, JM, Repapi, E, Schwessinger, R, Gosden, M, Brown, JM, Taylor, S, Cheong, PL, Hughes, JR, Higgs, DR, Gibbons, RJ
出版 2022Journal article -
15
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation 由 Godfrey, L, Crump, N, Thorne, R, Lau, I, Repapi, E, Dimou, D, Smith, A, Harman, J, Telenius, J, Oudelaar, A, Downes, D, Vyas, P, Hughes, J, Milne, T
出版 2019Journal article -
16
-
17
Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer. 由 Lenos, K, Grawenda, A, Lodder, K, Kuijjer, M, Teunisse, A, Repapi, E, Grochola, L, Bartel, F, Hogendoorn, P, Wuerl, P, Taubert, H, Cleton-Jansen, A, Bond, G, Jochemsen, A
出版 2012Journal article -
18
-
19
-
20
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 由 Kerry, J, Godfrey, L, Repapi, E, Tapia, M, Blackledge, N, Ma, H, Ballabio, E, O'Byrne, S, Ponthan, F, Heidenreich, O, Roy, A, Roberts, I, Konopleva, M, Klose, R, Geng, H, Milne, T
出版 2017Journal article